Safety and Preliminary Efficacy of Aleeto in Amyotrophic Lateral Sclerosis
Status:
Not yet recruiting
Trial end date:
2024-10-30
Target enrollment:
Participant gender:
Summary
This study is a single-center, randomized, double-blind, placebo parallel-controlled,
dose-escalation clinical study. The aim of this study was to evaluate the safety,
tolerability, and preliminary effect of Aleeto in adult patients with ALS, and to provide an
appropriate dose for the future clinical trial.